Traumeel - Healing*Edge Sciences
... Among the 1359 patients suffering from various injuries such as bruises, sprains, hematomas as well as degenerative and inflammatory conditions such as arthritis, frozen shoulder and carpal tunnel syndrome, 83% reported ‘good’ and ‘very good’ therapeutic results. No cases of adverse drug reactions w ...
... Among the 1359 patients suffering from various injuries such as bruises, sprains, hematomas as well as degenerative and inflammatory conditions such as arthritis, frozen shoulder and carpal tunnel syndrome, 83% reported ‘good’ and ‘very good’ therapeutic results. No cases of adverse drug reactions w ...
Naturopathic Medicine in Pain Management 4/11/2008
... and therefore increased intake is usually necessary • Protein-energy malnutrition is associated with impaired muscle function, decreased bone mass, immune dysfunction, anemia, reduced cognitive function, poor wound healing, delayed recovery from surgery, and ultimately increased morbidity and mortal ...
... and therefore increased intake is usually necessary • Protein-energy malnutrition is associated with impaired muscle function, decreased bone mass, immune dysfunction, anemia, reduced cognitive function, poor wound healing, delayed recovery from surgery, and ultimately increased morbidity and mortal ...
MISCELLANEOUS THERAPIES
... Cancer, you are supposed to be more likely to have abdominal disorders whereas if you are a Leo, your heart is your problem. So, knowing all this, you can take remedial action to preserve your health! On the other hand, if you believe this stuff, you might be in trouble. An interesting study was und ...
... Cancer, you are supposed to be more likely to have abdominal disorders whereas if you are a Leo, your heart is your problem. So, knowing all this, you can take remedial action to preserve your health! On the other hand, if you believe this stuff, you might be in trouble. An interesting study was und ...
Treatments - Interstitial Cystitis Association
... and urinary tract pain relievers (eg, AZO®) can help to alleviate mild pain. Other oral medications, though not approved specifically by the FDA for the treatment of IC, have been useful for treating the condition. These include acid-blockers like cimetidine (Tagamet®) and the antihistamine hydroxyz ...
... and urinary tract pain relievers (eg, AZO®) can help to alleviate mild pain. Other oral medications, though not approved specifically by the FDA for the treatment of IC, have been useful for treating the condition. These include acid-blockers like cimetidine (Tagamet®) and the antihistamine hydroxyz ...
Trial - American College of Cardiology
... 1. In adults with HTN, does initiating antihypertensive pharmacologic therapy at specific BP thresholds improve health outcomes? 2. In adults with HTN, does treatment with antihypertensive pharmacologic therapy to a specified BP goal lead to improvements in health outcomes? 3. In adults with HTN, do ...
... 1. In adults with HTN, does initiating antihypertensive pharmacologic therapy at specific BP thresholds improve health outcomes? 2. In adults with HTN, does treatment with antihypertensive pharmacologic therapy to a specified BP goal lead to improvements in health outcomes? 3. In adults with HTN, do ...
Uniform risk of clinical progression despite differences in utilization
... revascularization procedures for heart disease are well documented [5]. Zidovudine monotherapy has been prescribed less frequently for African Americans [6], women [7], and injection drug users, than for white men infected through sex with men and now injecting drug users [4,8], patients with low le ...
... revascularization procedures for heart disease are well documented [5]. Zidovudine monotherapy has been prescribed less frequently for African Americans [6], women [7], and injection drug users, than for white men infected through sex with men and now injecting drug users [4,8], patients with low le ...
documents 1 - Tainted Blood
... had chronic active hepatitis and 9 had cirrhosis (5 with esophageal varies). Histological Evidence suggested that non-A non-B hepatitis was mainly responsible, although the influence of other viruses could not be excluded. Serial liver biopsies showed progression from chronic persistent hepatitis to ...
... had chronic active hepatitis and 9 had cirrhosis (5 with esophageal varies). Histological Evidence suggested that non-A non-B hepatitis was mainly responsible, although the influence of other viruses could not be excluded. Serial liver biopsies showed progression from chronic persistent hepatitis to ...
Dose-Intensive Melphalan With Blood Stem Cell
... Simon Dubrey, Douglas V. Faller, Daniel G. Wright, Rodney H. Falk, and Martha Skinner The morbidity and lethality of AL amyloidosis is caused by the deposition of Ig light chains as fibrillar amyloid protein in vital organs, disrupting their function, and not by the generally low burden of clonal pl ...
... Simon Dubrey, Douglas V. Faller, Daniel G. Wright, Rodney H. Falk, and Martha Skinner The morbidity and lethality of AL amyloidosis is caused by the deposition of Ig light chains as fibrillar amyloid protein in vital organs, disrupting their function, and not by the generally low burden of clonal pl ...
Conventional treatments for ankylosing spondylitis
... efficacy of these drugs from large placebo controlled trials is lacking. Additionally, these drugs can cause treatment-limiting adverse effects. Intra-articular corticosteroid injection guided by arthrography, computed tomography, or magnetic resonance imaging is an effective means of reducing infla ...
... efficacy of these drugs from large placebo controlled trials is lacking. Additionally, these drugs can cause treatment-limiting adverse effects. Intra-articular corticosteroid injection guided by arthrography, computed tomography, or magnetic resonance imaging is an effective means of reducing infla ...
![MEDIscene Issue 5 June 2013 [pdf / 1.60MB]](http://s1.studyres.com/store/data/008006489_1-c17e8bd17c8f455f94b5ddd096b153ea-300x300.png)
MEDIscene Issue 5 June 2013 [pdf / 1.60MB]
... of the child’s eating and drinking potential, using appropriate strategies that promote safe and adequate nutritional intake. They support the child and carer in choosing between a number of feeding options and strategies where oral feeding is not be possible, help make meal times more pleasurable, ...
... of the child’s eating and drinking potential, using appropriate strategies that promote safe and adequate nutritional intake. They support the child and carer in choosing between a number of feeding options and strategies where oral feeding is not be possible, help make meal times more pleasurable, ...
Pulmonary Oedema
... PEF – the peak expiratory flow. Patients should take two readings per day, to show the variability of the disease. Spirometry – you can show the presence of asthma by demonstrating 15% improvement in FEV1 or PEF following the inhalation of a bronchodilator Exercise tests – these are often used to ...
... PEF – the peak expiratory flow. Patients should take two readings per day, to show the variability of the disease. Spirometry – you can show the presence of asthma by demonstrating 15% improvement in FEV1 or PEF following the inhalation of a bronchodilator Exercise tests – these are often used to ...
Cachexia
... Medication There are some medications that can be recommended for patients with cachexia. Some will have an antiinflammatory effect, others may improve appetite or alleviate symptoms such as nausea. However, medication alone will be effective only in few patients, and combination of drugs with exerc ...
... Medication There are some medications that can be recommended for patients with cachexia. Some will have an antiinflammatory effect, others may improve appetite or alleviate symptoms such as nausea. However, medication alone will be effective only in few patients, and combination of drugs with exerc ...
12 MAJOR SCIENTIFIC ADVANCES
... life. In order to better care for these patients, it is absolutely essential to detect diseases early or even to predict their onset. 850,000 patients suffer from Alzheimer’s disease, more than more than 150,000 patients suffer from Parkinson’s disease and more than 85,000 suffer from multiple scl ...
... life. In order to better care for these patients, it is absolutely essential to detect diseases early or even to predict their onset. 850,000 patients suffer from Alzheimer’s disease, more than more than 150,000 patients suffer from Parkinson’s disease and more than 85,000 suffer from multiple scl ...
Hyperthyroidism
... suppressed TSH with or without an elevated free T4 or T3 level.but if eye sign are present other tests are not needed.in patient with out eye sign (I 123)uptake with diffusely enlarged gland can confirm diagnosis. Other tests including:determining T3 level(in T3 toxicosis), anti TG antibodise,TPO an ...
... suppressed TSH with or without an elevated free T4 or T3 level.but if eye sign are present other tests are not needed.in patient with out eye sign (I 123)uptake with diffusely enlarged gland can confirm diagnosis. Other tests including:determining T3 level(in T3 toxicosis), anti TG antibodise,TPO an ...
Safety Aspects of Acupuncture in Palliative Care
... especially to lymph nodes, but also through distant spread, to bone, lung, brain and liver. Bone metastases are particularly common in cancers of the lung, breast, prostate, thyroid and kidney. A reasonable knowledge about the types of cancer and their therapeutic options, including surgery, chemoth ...
... especially to lymph nodes, but also through distant spread, to bone, lung, brain and liver. Bone metastases are particularly common in cancers of the lung, breast, prostate, thyroid and kidney. A reasonable knowledge about the types of cancer and their therapeutic options, including surgery, chemoth ...
NeuroStar TMS Therapy Patient Guide for Treating Depression
... 30dB or higher of noise reduction during treatment. In clinical trials, NeuroStar TMS Therapy had no effect on hearing when earplugs were used. The long term effectiveness of NeuroStar TMS Therapy for treating depression has not been evaluated in clinical studies where one-half of patients received ...
... 30dB or higher of noise reduction during treatment. In clinical trials, NeuroStar TMS Therapy had no effect on hearing when earplugs were used. The long term effectiveness of NeuroStar TMS Therapy for treating depression has not been evaluated in clinical studies where one-half of patients received ...
What does the M/SAB do - Myasthenia Gravis Foundation
... mother to the baby and can be effectively addressed if anticipated. The baby will need treatment, perhaps for several days to a week, until the MG antibodies from the mother have been removed from the baby or spontaneously broken down. Babies who have had TNMG have grown to be normal children. How w ...
... mother to the baby and can be effectively addressed if anticipated. The baby will need treatment, perhaps for several days to a week, until the MG antibodies from the mother have been removed from the baby or spontaneously broken down. Babies who have had TNMG have grown to be normal children. How w ...
June 2009 - State Pharmaceuticals Corporation of Sri Lanka
... propylthiouracil. It is important to warn the patient about agranulocytosis and neutropenia that may occur with thioureylenes. Agranulocytosis is an idiosyncratic reaction which is characterised by fever, sore throat and a granulocyte count of less than 500/mm3. Patients should be given written advi ...
... propylthiouracil. It is important to warn the patient about agranulocytosis and neutropenia that may occur with thioureylenes. Agranulocytosis is an idiosyncratic reaction which is characterised by fever, sore throat and a granulocyte count of less than 500/mm3. Patients should be given written advi ...
The addition of olanzapine to valproate or lithium for acute manic or
... (95% CI 59% to 76%) of patients receiving placebo and lithium or valproate improved less than the average patient receiving olanzapine and lithium or valproate. Patients with mixed and pure mania responded similarly to olanzapine augmentation, but the advantage of olanzapine was not statistically si ...
... (95% CI 59% to 76%) of patients receiving placebo and lithium or valproate improved less than the average patient receiving olanzapine and lithium or valproate. Patients with mixed and pure mania responded similarly to olanzapine augmentation, but the advantage of olanzapine was not statistically si ...
PROSTIVA RF Therapy Physician Presentation
... Patients with mild symptoms (AUA symptom score ≤ 7) and Patients with moderate or severe symptoms (AUA symptom score ≥ 8) who are not bothered by their symptoms ...
... Patients with mild symptoms (AUA symptom score ≤ 7) and Patients with moderate or severe symptoms (AUA symptom score ≥ 8) who are not bothered by their symptoms ...
PROSTIVA RF Therapy Physician Presentation
... Patients with mild symptoms (AUA symptom score ≤ 7) and Patients with moderate or severe symptoms (AUA symptom score ≥ 8) who are not bothered by their symptoms ...
... Patients with mild symptoms (AUA symptom score ≤ 7) and Patients with moderate or severe symptoms (AUA symptom score ≥ 8) who are not bothered by their symptoms ...
La Recherche
... dopamine and that it does not create lesions or organic modifications [3]. Everyone is trying to understand how it works. As I see it, a series of mechanisms act conjointly and simultaneously. Note that electrical stimulation is not a phenomenon that acts only at the end of an electrode… It has a di ...
... dopamine and that it does not create lesions or organic modifications [3]. Everyone is trying to understand how it works. As I see it, a series of mechanisms act conjointly and simultaneously. Note that electrical stimulation is not a phenomenon that acts only at the end of an electrode… It has a di ...
Kiadis Pharma`s Orphan Drug Designation for ATIR101
... causing severe Graft-versus-Host-Disease (GVHD). The T-cells in ATIR101™ will help fight infections and remaining tumor cells and thereby bridge the time until the immune system has fully re-grown from stem cells in the transplanted graft. In ATIR101™, T-cells that would cause GVHD are eliminated fr ...
... causing severe Graft-versus-Host-Disease (GVHD). The T-cells in ATIR101™ will help fight infections and remaining tumor cells and thereby bridge the time until the immune system has fully re-grown from stem cells in the transplanted graft. In ATIR101™, T-cells that would cause GVHD are eliminated fr ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.